Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30599654 | 1.00 | MAPT (0.42) | MAPTTDP1L3MBTL1KMT2ATHRB | |
| SCHEMBL13636994 | 0.98 | TDP1 (0.41) | MAPTTDP1L3MBTL1KMT2ATHRB | |
| SCHEMBL31520191 | 0.96 | TSHR (0.41) | MAPTTDP1L3MBTL1KMT2ATHRB | |
| SCHEMBL102915 | 0.96 | THRB (0.44) | MAPTTDP1L3MBTL1KMT2ATHRB | |
| SCHEMBL29809767 | 0.96 | THRB (0.44) | MAPTTDP1L3MBTL1KMT2ATHRB | |
| SCHEMBL17301299 | 0.95 | THRB (0.41) | MAPTTDP1L3MBTL1KMT2ATHRB | |
| SCHEMBL24194107 | 0.95 | NPC1 (0.44) | MAPTTDP1L3MBTL1KMT2ATHRB | |
| SCHEMBL9106590 | 0.95 | HTT (0.44) | MAPTTDP1L3MBTL1KMT2ATHRB | |
| SCHEMBL18803342 | 0.95 | NPC1 (0.44) | MAPTTDP1L3MBTL1KMT2ATHRB | |
| SCHEMBL20883271 | 0.95 | NPC1 (0.44) | MAPTTDP1L3MBTL1KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4486575-B1 | OVERT SECURITY FEATURES | SICPA HOLDING SA (CH) | 2025-10-29 | — | — | EP | disclosed |
| US-20250303775-A1 | OVERT SECURITY FEATURES | SICPA HOLDING SA (CH) | 2025-10-02 | — | — | US | disclosed |
| WO-2023165863-A1 | OVERT SECURITY FEATURES | SICPA HOLDING SA (CH) | 2023-09-07 | — | — | WO | disclosed |
| CN-105899642-B | Composite marking based on chiral liquid crystal precursors and modified resins | 锡克拜控股有限公司 | 2021-12-14 | — | — | CN | disclosed |
| CN-105899643-B | Salt-free composite marking based on chiral liquid crystal precursors comprising chiral acrylate dopants | 锡克拜控股有限公司 | 2021-07-16 | — | — | CN | disclosed |
| US-10654307-B2 | Rotogravure printing processes for producing optically variable security features | SICPA HOLDING SA (CH) | 2020-05-19 | — | — | US | disclosed |
| US-10611919-B2 | Salt-free composite marking based on chiral liquid crystal precursors comprising chiral acrylate dopants | SICPA HOLDING SA (CH) | 2020-04-07 | — | — | US | disclosed |
| EP-3057801-B1 | ROTOGRAVURE PRINTING PROCESSES FOR PRODUCING OPTICALLY VARIABLE SECURITY FEATURES | SICPA HOLDING SA (CH) | 2019-08-14 | — | — | EP | disclosed |
| US-10308872-B2 | Composite marking based on chiral liquid crystal precursors and modifying resins | SICPA HOLDING SA (CH) | 2019-06-04 | — | — | US | disclosed |
| EP-3066175-B1 | SALT-FREE COMPOSITE MARKING BASED ON CHIRAL LIQUID CRYSTAL PRECURSORS COMPRISING CHIRAL ACRYLATE DOPANTS | SICPA HOLDING SA (CH) | 2019-03-20 | — | — | EP | disclosed |
| EP-2509793-A1 | MARKING BASED ON MODIFIED CHIRAL LIQUID CRYSTAL POLYMERS | SICPA Holding SA (CH) | 2012-10-17 | — | — | EP | disclosed |
| WO-2012076533-A1 | SIMPLIFIED CONTROL OF COLOR SHIFTING PROPERTIES OF A CHIRAL LIQUID CRYSTAL POLYMER | SICPA HOLDING SA (CH) | 2012-06-14 | — | — | WO | disclosed |
| US-20120141745-A1 | SIMPLIFIED CONTROL OF COLOR SHIFTING PROPERTIES OF A CHIRAL LIQUID CRYSTAL POLYMER | SICPA HOLDING SA (CH) | 2012-06-07 | — | — | US | disclosed |
| US-20120141697-A1 | COMPOSITE MARKING BASED ON CHIRAL LIQUID CRYSTAL PRECURSORS | SICPA HOLDING SA (CH) | 2012-06-07 | — | — | US | disclosed |
| WO-2011069692-A1 | MARKING BASED ON MODIFIED CHIRAL LIQUID CRYSTAL POLYMERS | SICPA HOLDING SA (CH) | 2011-06-16 | — | — | WO | disclosed |
| WO-2011069691-A1 | MARKING BASED ON CHIRAL LIQUID CRYSTAL POLYMERS | SICPA HOLDING SA (CH) | 2011-06-16 | — | — | WO | disclosed |
| US-20110133445-A1 | MARKING BASED ON MODIFIED CHIRAL LIQUID CRYSTAL POLYMERS | SICPA HOLDING S.A. (CH) | 2011-06-09 | — | — | US | disclosed |
| US-20110135890-A1 | CHIRAL LIQUID CRYSTAL POLYMER MARKING | SICPA HOLDING S.A. (CH) | 2011-06-09 | — | — | US | disclosed |
| US-20110135889-A1 | MARKING BASED ON CHIRAL LIQUID CRYSTAL POLYMERS | SICPA HOLDING S.A. (CH) | 2011-06-09 | — | — | US | disclosed |
| US-20110135853-A1 | MODIFIED MARKING BASED ON CHIRAL LIQUID CRYSTAL POLYMERS | SICPA HOLDING S.A. (CH) | 2011-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120141745-A1 | SIMPLIFIED CONTROL OF COLOR SHIFTING PROPERTIES OF A CHIRAL LIQUID CRYSTAL POLYMER | CRY1, SET, RCC1 | MAPT 322/4885TDP1 4237/4885L3MBTL1 3186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.